Evaluation of paroxysmal nocturnal hemoglobinuria screening by flow cytometry through multicentric interlaboratory comparison in four countries. Debliquis A, Wagner-Ballon O, Le Garff-Tavernier M, Fossat C, Chatelain B, Letestu R, Drénou B; HPNAFCGroup. Am J Clin Pathol. 2015 Dec;144(6):858-68.

CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling. Arnaud MP, Vallée A, Robert G, Bonneau J, Le Roy C, Varin-Blank N, Rio AG, Troadec MB, Galibert MD, Gandemer V. Blood 2015 Oct 8;126(15):1802-12.

Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderlypatients with chronic lymphocytic leukemia. Dartigeas C, Van Den Neste E, Berthou C, Maisonneuve H, Leprêtre S, Dilhuydy MS, Béné MC, Nguyen-Khac F, Letestu R, Cymbalista F, De Guibert S, Aurran T, Laribi K, Vilque JP, Tournilhac O, Delmer A,Feugier P, Cazin B, Michallet AS, Lévy V, Troussard X, Delepine R, Tavernier E, Colombat P, Leblond V. Leuk Lymphoma. 2015 Sep 28:1-7.

Mutation of Vav1 adaptor region reveals a new oncogenic activation. Razanadrakoto L, Cormier F, Laurienté V, Dondi E, Gardano L, Katzav S, Guittat L, Varin-Blank N. Oncotarget. 2015 Feb 10;6(4):2524-37.

Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previouslyuntreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 study. Dupuis J, Morschhauser F, Ghesquières H, Tilly H, Casasnovas O, Thieblemont C, Ribrag V, Bossard C, LeBras F, Bachy E, Hivert B, Nicolas-Virelizier E, Jardin F, Bastie JN, Amorim S, Lazarovici J, Martin A, Coiffier B. Lancet Haematol. 2015 Apr;2(4):e160-5.

Adult Onset Asthma and Periocular Xanthogranuloma (AAPOX), a Rare Entity With a Strong Link to IgG4-Related Disease: An Observational Case Report Study. London J, Martin A, Soussan M, Badelon I, Gille T, Uzunhan Y, Giroux-Leprieur B, Warzocha U, Régent A,Galatoire O, Dhote R, Abad S. Medicine (Baltimore). 2015 Oct;94(43):e1916.

Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations. Godier A, Martin AC, Leblanc I, Mazoyer E, Horellou MH, Ibrahim F, Flaujac C, Golmard JL, Rosencher N, Gouin-Thibault I. Thromb Res. 2015 Oct;136(4):763-8.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets. de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, Dartigues P, Fabiani B, Ledoux-Pilon A, Montagne K, Molina T, Patey M, Tas P, Peoch M, Petit B, Petrella T, Picquenot JM, Rousset T, Rousselet MC, Soubeyran I, Thiebault S, Tournilhac O, Xerri L, Gisselbrecht C, Haioun C, Delsol G, Gaulard P. Haematologica. 2015 Sep;100(9):e361-4.

Chanarin-Dorfman syndrome in a 7-year-old child: when myophathy and skin involvement are all but one. Barnérias C, Bassez G, Schischmanoff O. Med Sci (Paris). 2015 Nov;31 Spec No 3:11-3.

Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab forchronic lymphocytic leukemia: the French intergroup experience. Fornecker LM, Aurran-Schleinitz T, Michallet AS, Cazin B, Guieze R, Dilhuydy MS, Zini JM, Tomowiak C, Lepretre S, Cymbalista F, Brion A, Feugier P, Delmer A, Leblond V, Ysebaert L. Am J Hematol. 2015 Jun;90(6):511-4.

Systemic granulomatosis and polyarthritis with pitting edema in B-chronic lymphocytic leukemia. Grignano E, Mekinian A, Caux F, Soussan M, Cymbalista F, Fain O. Joint Bone Spine. 2015 Jul;82(4):294-5.

Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis. Herbaux C, Duployez N, Badens C, Poret N, Gardin C, Decamp M, Eclache V, Daliphard S, Murati A, Cony-Makhoul P, Cheze S, Beve B, Lacoste C, Prebet T, Hunault-Berger M, Maloisel F, Renneville A, Figeac M, Stamatoullas-Bastard A, Bastard C, Fenaux P, Preudhomme C, Rose C; GFM (Groupe Francophone desMyelodysplasies). Am J Hematol. 2015 Aug;90(8):737-8.

Selective upregulation of the expression of plasma membrane calcium ATPase isoforms upon differentiationand 1,25(OH)2D3-vitamin treatment of colon cancer cells. Ribiczey P, Papp B, Homolya L, Enyedi Á, Kovács T. Biochem Biophys Res Commun. 2015 Aug 14;464(1):189-94.

Loss of endoplasmic reticulum calcium pump expression in choroid plexus tumours. Ait-Ghezali L, Arbabian A, Jeibmann A, Hasselblatt M, Hallaert GG, Van den Broecke C, Gray F, Brouland JP, Varin-Blank N, Papp B. Neuropathol Appl Neurobiol. 2014 Oct;40(6):726-35.

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observationalstudy from the European Research Initiative on Chronic Lymphocytic Leukemia. Moreno C, Montillo M, Panayiotidis P, Dimou M, Bloor A, Dupuis J, Schuh A, Norin S, Geisler C, Hillmen P, Doubek M, Trněný M, Obrtlikova P, Laurenti L, Stilgenbauer S, Smolej L, Ghia P, Cymbalista F, Jaeger U, Stamatopoulos K, Stavroyianni N, Carrington P, Zouabi H, Leblond V, Gomez-Garcia JC, Rubio M, Marasca R, Musuraca G, Rigacci L, Farina L, Paolini R, Pospisilova S, Kimby E, Bradley C, Montserrat E. Haematologica. 2015 Apr;100(4):511-6.

Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma. Bernard S, Danglade D, Gardano L, Laguillier C, Lazarian G, Roger C, Thieblemont C, Marzec J, Gribben J, Cymbalista F, Varin-Blank N, Ledoux D, Baran-Marszak F. Int J Cancer. 2015 Jun 15;136(12):2761-74

Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients. Quinquenel A, Al Nawakil C, Baran-Marszak F, Eclache V, Letestu R, Khalloufi M, Boubaya M, Le Roy C,Varin-Blank N, Delmer A, Levy V, Ajchenbaum-Cymbalista F. Am J Hematol. 2015 Jan;90(1):E5-8